Company Filing History:
Years Active: 2010-2011
Title: Alban Sidhu: Innovator in Cancer Treatment
Introduction
Alban Sidhu is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 2 patents, Sidhu's work focuses on inhibitors of cdc phosphatases, which play a crucial role in cancer therapy.
Latest Patents
Sidhu's latest patents include groundbreaking inventions aimed at combating cancer. The first patent involves novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units, which inhibit the cdc25 phosphatases, particularly cdc25-C phosphatase. These compounds have the potential to be used in the treatment of cancer. The second patent focuses on 4,7-dioxobenzothiazole-2-carboxamide derivatives, which also inhibit cdc25 phosphatases, specifically cdc25-C phosphatase, and can be utilized in cancer treatment.
Career Highlights
Alban Sidhu is currently associated with Ipsen Pharma S.a.s., where he continues to advance his research in the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments for cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Sidhu collaborates with esteemed colleagues, including Marie-Odile Galcera-Contour and Grégoire Prevost. These partnerships enhance the innovative potential of his research and contribute to the advancement of cancer therapies.
Conclusion
Alban Sidhu's contributions to cancer treatment through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical field. His innovative compounds have the potential to make a meaningful impact on cancer therapy.